NextTrip, Inc. (NTRP)
| Market Cap | 3.41M |
| Revenue (ttm) | 754,818 |
| Net Income (ttm) | -8.62M |
| Shares Out | 1.42M |
| EPS (ttm) | -10.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,366 |
| Open | 2.400 |
| Previous Close | 2.370 |
| Day's Range | 2.400 - 2.585 |
| 52-Week Range | 1.475 - 6.810 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2024 |
About NTRP
NextTrip, Inc. provides travel technology solutions in the United States. It offers NXT2.0, a booking platform, enables to book customized travel, including vacation packages, airline tickets, hotel reservations, tours and activities, curated journeys, wellness, and business and group travel. The company was formerly known as Sigma Additive Solutions, Inc. and changed its name to NextTrip, Inc. in March 2024. NextTrip, Inc. is based in Santa Fe, New Mexico. [Read more]
Financial Performance
In 2023, NextTrip's revenue was $458,752, an increase of 19.83% compared to the previous year's $382,832. Losses were -$7.34 million, 45.8% more than in 2022.
Financial numbers in USD Financial StatementsNews
NextTrip Prepares Compass.tv for Soft Launch, Signs New Content Creators
Seamlessly Translates Content into Commerce Opportunities using the NextTrip Booking Engine SANTA FE, NM / ACCESSWIRE / October 1, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the ...
NextTrip Introduces Group Booking Technology Platform to Streamline and Simplify Travel for Groups
New Flexible Solution Designed to Reduce Friction, Empowering Customers When Reserving Group Travel SUNRISE, FL / ACCESSWIRE / July 30, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or...
NextTrip, Inc. Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements
SUNRISE, FL / ACCESSWIRE / July 19, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel technology company, received a notice (the "Notice") from the listing qual...
NextTrip Taps Dooya Media Group To Launch Compass.TV
Dynamic Content-to-Commerce FAST Channel Reinvents Monetization Models SUNRISE, FL / ACCESSWIRE / July 18, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a travel tec...
NextTrip Launches FlexPay Travel Payment Options for Bookings
Allows Consumers to Pay for Accommodations Through Interest-free Installments with Convenient and Flexible Payment Options when Booking Travel Seamless Integration Enables Marketing Opportunities in S...
NextTrip, Inc Receives Nasdaq Notification Regarding Late 10K Filing and Continued Listing Requirements
SUNRISE, FL / ACCESSWIRE / June 21, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip", "we," "our," or the "Company"), a travel technology company, has received a notice (the "Notice") from the listing ...
NextTrip Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
SUNRISE, FL / ACCESSWIRE / April 2, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip", "we," "our," or the "Company"), a travel technology company, has engaged international investor relations specialis...
Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates
NEW YORK, Nov. 20, 2020 /PRNewswire/ -- Neurotrope, Inc. (NASDAQ: NTRP) ("Neurotrope" or the "Company") announced today that its Board of Directors has approved the conditional distribution and set th...
Neurotrope Shareholders to Own 49 Percent of Petros Under Revised Merger Agreement with Metuchen
NEW YORK and MANALAPAN TOWNSHIP, N.J., Sept. 30, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C., a privately held biopharmaceutical company focused on innova...
Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company
NEW YORK and MANALAPAN TOWNSHIP, N.J., May 18, 2020 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C., a privately held biopharmaceutical company ("Metuchen"), focus...
Neurotrope Rips 150% Higher On Improved Alzheimer's Data, NIH Funding
Shares of thinly-traded microcap biopharma Neurotrope Inc (NASDAQ: NTRP) gap-opened sharply higher on above 50 times average volume following a corporate update from the company.
Neurotrope's stock plummets on heavy volume after disappointing trial of Alzheimer's treatment
Shares of Neurotrope Inc. NTRP, -77.95% plummeted 79% on heavy volume Monday, to below the $1 mark for the first time in six years, after the biopharmaceutical company said its Alzheimer's disease (AD...
Why Neurotrope Is Plunging On Heavy Volume
Shares of thinly-traded nano-cap biotech Neurotrope Inc (NASDAQ: NTRP) were plummeting Monday following an adverse clinical trial readout.